Advertising Drug Firms Seek Web Guidance Big drug makers, including Eli Lilly and Pfizer, are heading to Washington to press for guidance from the FDA on marketing prescription drugs online.
Analysis of a dozen published studies testing possible new uses for a Pfizer Inc. epilepsy drug found that reporting of the results was often misleading, indicating the medicine worked better than internal company documents showed.
As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter and other Web sites.
The Health Care Select Sector SPDRS ETF, XLV has run into extremely overbought territory- so much so that it's last close had a 2-period RSI of more than 90 for four consecutive days.
No comments:
Post a Comment